Evolution of Multiple Sclerosis Lesions on Serial Contrast-Enhanced T1-Weighted and Magnetization-Transfer MR Images

References

1. ↵
   Whitaker JN, McFarland HF, Rudge P, Reingold SC, Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Multiple Sclerosis 1995;1:37-47

   Abstract/FREE Full Text
2. ↵
   Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16

   CrossRefPubMedWeb of Science
3. ↵
   Miller DH, Grossman RI, Reingold SC, McFarland HF, The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24

   Abstract/FREE Full Text
4. ↵
   Runge VM, Price AC, Kirshner HS, et al. MR imaging of MS: a study of pulse-techniques efficiency. AJR Am J Roentgenol 1984;143:1015-1026

   PubMedWeb of Science
5. Ormerod IEC, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987;110:1579-1616

   Abstract/FREE Full Text
6. Goodkin DE, Rudick RA, Ross JS, The use of brain magnetic resonance imaging in multiple sclerosis. Arch Neurol 1994;51:505-516

   CrossRefPubMedWeb of Science
7. ↵
   Kappos L, Stadt D, Keil W, el al An attempt to quantify magnetic resonance imaging in multiple sclerosis: correlation with clinical parameters. Neurosurg Rev 1987;10:133-135

   CrossRefPubMedWeb of Science
8. ↵
   Gass A, Barker GJ, Kidd D, el al Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62-67

   CrossRefPubMedWeb of Science
9. Filippi M, Paty DW, Kappos L, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995;45:255-260

   Abstract/FREE Full Text
10. Gasperini C, Horsfield MA, Thorpe JW, et al. Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters. J Magn Reson Imaging 1996;6:580-584

    PubMedWeb of Science
11. ↵
    Walderveen MAA, Barkhoff F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-1690

    Abstract/FREE Full Text
12. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI, Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636

    PubMedWeb of Science
13. ↵
    Loevner LA, Grossman RI, McGowan JC, Ramer KN, Cohen JA, Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol 1995;16:1473-1479

    Abstract
14. ↵
    Hiehle JF, Grossman RI, Ramer KN, Gonzalez-Scarano F, Cohen JA, Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77

    Abstract
15. van Waesberghe JHTM, Castelijns JA, Scheltens Ph, et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis. Magn Reson Imaging 1997;15:155-162

    CrossRefPubMedWeb of Science
16. ↵
    van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288

    Abstract/FREE Full Text
17. ↵
    Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez-Scarano F, Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491

    PubMedWeb of Science
18. Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995;16:225-231

    Abstract/FREE Full Text
19. ↵
    Lai HM, Davie CA, Gass A, et al. Serial magnetization transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 1997;244:308-311

    CrossRefPubMedWeb of Science
20. van Waesberghe JHTM, van Walderveen MAA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19:675-683

    Abstract
21. ↵
    Poser CM, Paty D, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231

    CrossRefPubMedWeb of Science
22. ↵
    Kurtzke JF, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452

    Abstract/FREE Full Text
23. ↵
    Gallagher HL, MacManus DG, Webb SL, Miller DH, A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis. J Magn Reson Imaging 1997;7:439-441

    PubMedWeb of Science
24. ↵
    Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476

    Abstract/FREE Full Text
25. ↵
    van Waesberghe JHTM, van Walderveen MAA, Castelijns JA, et al. Natural history of hypointense lesions in multiple sclerosis. J Neurol 1997;244(Suppl 3):87
26. ↵
    Petrella JR, Grossman RI, McGowan JC, Campbell G, Cohen JA, Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR Am J Neuroradiol 1996;17:1041-1049

    Abstract
27. Hiehle JF, Lenkinski RE, Grossman RI, et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994;32:285-293

    PubMedWeb of Science
28. Campi A, Filippi M, Comi G, Scotti G, Geverini S, Dousset V, Magnetization transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis. Neuroradiology 1996;38:115-119

    PubMedWeb of Science
29. ↵
    Kepes JJ, Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993;33:18-27

    CrossRefPubMedWeb of Science
30. Ishihara O, Yamaguchi Y, Matsuishi T, et al. Multiple ring enhancement in a case of acute reversible demyelinating disease of childhood suggestive of acute multiple sclerosis. Brain Dev 1984;6:401-406

    PubMed
31. Youl BD, Kermode AG, Thompson AJ, et al. Destructive lesions in demyelinating disease. J Neurol Neurosurg Psychiatry 1991;54:288-292

    Abstract/FREE Full Text
32. ↵
    Larsson HBW, Thomsen C, Frederiksen J, et al. In vivo magnetic resonance diffusion measurements in the brain of patients with multiple sclerosis. Magn Reson Imaging 1992;10:7-12

    CrossRefPubMedWeb of Science
33. Droogan AG, Clark CA, Werring DJ, Barker GJ, Miller DH, Navigated spin-echo diffusion-weighted imaging in clinical phenotypes of multiple sclerosis (abstr). In: Proceedings of the 6th Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine. Sydney, Australia: 1998:117
34. ↵
    Heide AC, Richards TL, Alvord EC, et al. Diffusion imaging in experimental encephalomyelitis. Magn Reson Med 1993;29:478-484

    PubMedWeb of Science
35. Verhoye MR, Gravenmade EJ, Raman ER, et al. In vivo non-invasive determination of abnormal water diffusion in the rat brain studied in an animal model for multiple sclerosis by diffusion-weighted NMR imaging. Magn Reson Imaging 1996;14:521-532

    CrossRefPubMedWeb of Science